Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Preclinical CRO Market

Preclinical CRO Market Share

Report ID: GMI2860
Published Date: Mar 2023
Report Format: PDF

Download Free Sample

Preclinical CRO Market Share

Prominent market players operating in the preclinical CRO industry include:

Charles River Laboratories
Laboratory Corporation of America Holdings
CON plc
Pharmaceutical Product Development

These industry players majorly concentrate on various strategies including collaborations, acquisitions, mergers and partnerships to create a global footprint and sustain market competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for preclinical CRO exceeded a valuation of USD 5 billion in 2022 and is set to progress at more than 7.5% CAGR over the next 10 years owing to increasing R&D expenditure on early-stage development, coupled with the growing number of drugs in the preclinical phase.

Medical device companies segment is anticipated to depict more than 7.5% CAGR between 2023 and 2032 due to the mounting demand for special preclinical CRO services that fulfill the personalized needs of medical device and diagnostics companies.

Toxicology testing segment is projected to surpass USD 4 billion by 2032 as toxicology studies are a legal prerequisite of drug development.

North America preclinical CRO market held more than 43% business share in 2022 on account of consistent drug development and the strong presence of key medical device manufacturers in the region.